Transmission Dynamics of Carbapenemase Genes in CREC: New Evidence from Guangdong Teaching Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) represents a growing threat to global public health, particularly within hospital environments where multidrug resistance can complicate infection management. The COVID-19 pandemic has further intensified this challenge by altering antibiotic prescribing behaviors and healthcare practices, creating conditions conducive to the emergence and propagation of resistant bacterial strains. Despite these developments, detailed molecular characterizations of carbapenemase-encoding genes (CEGs) within CREC—especially regarding their transmission dynamics during the pandemic—remain scarce. The recent study by Chen et al. (2025) addresses this critical gap by examining the prevalence, genetic context, and dissemination patterns of CEGs in CREC isolates from eight teaching hospitals in Guangdong province, China, collected between December 2022 and June 2024.

Key Innovation from the Reference Study

The principal innovation of this work lies in its integrative approach—combining molecular genotyping, plasmid elimination, conjugation assays, and epidemiological data—to map both the genetic architecture and horizontal transmission potential of CEGs in a real-world clinical context. Notably, the study dissects the chromosomal versus plasmid localization of resistance genes, quantifies their transmission rates, and links these patterns to patient demographics and clinical settings. This granularity provides a foundation for targeted interventions and enhances our understanding of antimicrobial resistance (AMR) evolution in healthcare environments.

Methods and Experimental Design Insights

The study analyzed 54 non-duplicate CREC isolates using a suite of molecular and microbiological techniques. Key protocols included:

• Variable Temperature SDS Plasmid Elimination and PCR: Used to discriminate between chromosomal and plasmid carriage of CEGs, enabling precise mapping of gene localization.
• Broth Microdilution Antimicrobial Susceptibility Testing: Employed to determine resistance phenotypes across multiple antibiotics, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Plasmid Conjugation Assays: Quantified the horizontal transfer efficiency of CEGs, using recipient strains and PCR confirmation of successful gene acquisition.
• ERIC-PCR Genotyping and NTSYS Clustering: Facilitated the classification of isolates into genotypes and assessment of clonal relationships, revealing the diversity of circulating CREC strains.

Such multi-layered methodology enables robust linkage between molecular findings and epidemiological trends, a key strength relative to narrower genotypic surveys.

Core Findings and Why They Matter

The study reports several significant findings:

• High Prevalence of Carbapenemase-Encoding Genes: 85.19% of CREC isolates harbored CEGs, with the blaNDM−1 gene being most frequent—detected on both chromosomes and plasmids in 33.33% and exclusively on plasmids in 46.30% of isolates. The blaIMP and blaKPC−2 genes also appeared, though less commonly.
• Extensive Plasmid-Mediated Transmission: Plasmid conjugation assays achieved a 95.65% success rate for CEG transfer, underscoring the efficiency of horizontal gene dissemination in clinical settings. The blaNDM−1 and blaIMP genes showed particularly high transferability rates.
• Association with Multidrug Resistance: CEG-positive strains exhibited significantly higher resistance to several antibiotic classes compared to CEG-negative strains, highlighting the clinical impact of these genes on treatment outcomes.
• Mobile Genetic Element Diversity: Six types of mobile elements were identified, with ISEcp1 being most prevalent (87.04%). Some isolates carried up to four distinct element types, indicating complex resistance gene mobilization pathways.
• Genotypic and Epidemiologic Patterns: ERIC-PCR classified isolates into 17 genotypes, with type E and G most common, distributed across multiple departments. Higher CEG detection rates were observed in male patients, the elderly, respiratory medicine wards, and sputum samples.

Together, these results provide compelling evidence that both chromosomal and plasmid reservoirs drive the persistence and spread of carbapenem resistance. The capacity for rapid horizontal gene transfer, especially via plasmids, poses a substantial challenge for infection control and antibiotic stewardship.

Comparison with Existing Internal Articles

Several recent reviews and workflow articles complement the reference study’s findings, broadening the context for AMR research tools and strategies. The article "Transmission of Carbapenemase Genes in CREC: Insights from Guangdong Hospitals" echoes the high prevalence of multidrug resistance and efficient horizontal gene transfer described in the reference work, while also emphasizing the practical challenges faced by infection control teams. Additionally, protocol-focused resources—such as "Cefotaxime in Antimicrobial Resistance Research: Protocols & Pitfalls"—highlight how model antibiotics like Cefotaxime can be leveraged for dissecting beta-lactam resistance mechanisms and modeling Gram-positive and Gram-negative bacterial infections, connecting laboratory workflows with the clinical genomics highlighted by Chen et al.

Other internal literature, such as "Cefotaxime in Antimicrobial Resistance: Gene Dynamics & Assay Precision", underscores the importance of integrating genetic transmission data with assay design when studying resistance evolution. The synergy between these approaches and the reference study’s rigorous mapping of plasmid versus chromosomal gene carriage demonstrates the value of combining epidemiological and mechanistic insights for a holistic understanding of resistance spread.

Protocol Parameters

• Plasmid elimination (SDS method): Incubate CREC isolates at 42°C in the presence of 0.1% SDS for 16–24 hours, then confirm plasmid loss by PCR and antimicrobial susceptibility testing.
• Plasmid conjugation: Mix donor and recipient strains at a 1:1 ratio, incubate on non-selective agar at 37°C for 18–24 hours, then select transconjugants on antibiotic-containing media.
• Broth microdilution for susceptibility testing: Prepare serial dilutions of test antibiotics, inoculate with standard bacterial suspensions (0.5 McFarland), and incubate at 37°C for 16–20 hours; interpret MIC values per CLSI/EUCAST guidelines.
• ERIC-PCR genotyping: Use standardized ERIC primers and PCR conditions; analyze banding patterns with NTSYS software to determine clonal relationships.

Where literature does not specify, researchers should optimize conditions based on the bacterial strain and laboratory setup, ensuring consistent validation with reference controls.

Limitations and Transferability

While the study offers a comprehensive snapshot of CEG epidemiology in Guangdong, its findings are primarily applicable to tertiary hospital settings within this region and the COVID-19 time frame. The focus on CREC, while justified by its rising prevalence, may not capture the full spectrum of resistance dynamics present in other Enterobacteriaceae or community settings. Additionally, the use of selective culture and PCR-based detection could overlook low-abundance or novel resistance determinants not targeted by the assays. Nevertheless, the demonstration of both vertical and horizontal gene transmission, and the identification of diverse mobile genetic elements, are likely generalizable to other nosocomial pathogens where plasmid-driven resistance is a concern.

Research Support Resources

For laboratories aiming to replicate or extend these findings, access to well-characterized antibiotics is essential for both selective culturing and resistance phenotyping. Cefotaxime (SKU BA1012) is a third-generation cephalosporin antibiotic noted for its beta-lactamase resistance and broad-spectrum activity against Gram-positive and Gram-negative bacteria. Its properties make it especially valuable for modeling antimicrobial resistance and bacterial infection dynamics in vitro. Researchers can incorporate Cefotaxime into plasmid-mediated resistance screening and mechanistic studies, as described in the internal protocol article. For optimal results, freshly prepared solutions should be used, and storage should adhere to recommended conditions to maintain compound stability. For further workflow guidance, APExBIO provides detailed product information and technical support.